» Articles » PMID: 34593358

Cardiac Stereotactic Ablative Radiotherapy for Refractory Ventricular Arrhythmias: A Radical Alternative? A Narrative Review of Rationale and Cardiological Aspects

Overview
Publisher Elsevier
Specialty Radiology
Date 2021 Oct 1
PMID 34593358
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Ventricular arrhythmias are serious life-threatening cardiac disorders. Despite many technological improvements, a non-negligible number of patients present refractory ventricular tachycardias, resistant to a catheter ablation procedure, placing these patients in a therapeutic impasse. Recently, a cardiac stereotactic radioablative technique has been developed to treat patients with refractory ventricular arrhythmias, as a bail out strategy. This new therapeutic option historically brings together two fields of expertise unknown to each other, pointing out the necessity of an optimal partnership between cardiologists and radiation oncologists. As described in this narrative review, the understanding of cardiological aspects of the technique for radiation oncologists and treatment technical aspects comprehension for cardiologists represent a major challenge for the application and the future development of this promising treatment.

Citing Articles

Patient-specific quantification of cardiorespiratory motion for cardiac stereotactic radioablation treatment planning.

Petzl A, Benali K, Mbolamena N, Dyrda K, Rivard L, Seidl S Heart Rhythm O2. 2024; 5(4):234-242.

PMID: 38690147 PMC: 11056453. DOI: 10.1016/j.hroo.2024.03.006.


Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies.

Galietta E, Strolin S, Bisello S, Cellini F, Lovato L, Ravegnini G In Vivo. 2023; 37(3):963-971.

PMID: 37103087 PMC: 10188005. DOI: 10.21873/invivo.13170.


Stereotactic Arrhythmia Radioablation Treatment of Ventricular Tachycardia: Current Technology and Evolving Indications.

Guarracini F, Tritto M, Di Monaco A, Mariani M, Gasperetti A, Compagnucci P J Cardiovasc Dev Dis. 2023; 10(4).

PMID: 37103051 PMC: 10143260. DOI: 10.3390/jcdd10040172.